Skip to main content

Donald Trump, Catalonia, Nxivm: Your Thursday Briefing - The New York Times

posted onOctober 19, 2017
>

Article snippet: (Want to get this briefing by email? Here’s the sign-up.) Good morning. Here’s what you need to know: • Let’s start with good news. A radically new treatment genetically reboots a patient’s own immune cells to kill cancer. U.S. drug regulators approved the new therapy for adults with aggressive forms of a blood cancer, non-Hodgkin’s lymphoma, who have undergone two regimens of chemotherapy that failed. It was hailed as “another milestone in the development of a whole new scientific paradigm for the treatment of serious diseases.” _____ • In the United States, the debate turned acrid over President Trump’s condolence call to the widow of Sgt. La David T. Johnson, above, one of four soldiers killed in Niger this month. Sergeant Johnson’s mother said that Mr. Trump did, in fact, tell his widow that he “knew what he signed up for.” The president has denied this. Several families of fallen soldiers said that they had not heard from the president. Separately, Attorney General Jeff Sessions testified before the Senate Judiciary Committee, but refused to discuss his conversations with Mr. Trump about Russia or the firing of James Comey, the former F.B.I. director. _____ • The Islamic State may be reeling, but it is far from vanquished. Counterterrorism officials are bracing for the jihadist group to return to its guerrilla roots. It still has up to 10,000 fighters in Iraq, Syria and elsewhere. And Al Qaeda is vying for a comeback with a charismatic leader: Osama bin Lad... Link to the full article to read more

Emotional score for this article